Clinical Trials Browser

Phase 1 × pertuzumab × Tumor-Agnostic × Clear all

NCT00027027 2015-07-27

Safety Study of rhuMAb 2C4 to Treat Advanced Solid Tumors

Phase 1 Completed

21 enrolled 17 charts

Neoplasms